BioMarin Pharmaceutical, Inc. BMRN
BioMarin had a really solid performance yesterday after we signaled some contracts in our premarket report, the BMRN 03/16 $80 & 85 Calls. The stock ran from 81.01 to 84.19 facilitating some modest but solid intraday moves in our contracts.
The $80 Calls ran from 4.40-6.00 for a 32% rise, and the $85’s traded from 2.70-3.50, a gain of 26%
With a strong close at 83.28, and a lot of ground to cover to recoup the losses the stock has seen in the month of February, we’ll look for BMRN to establish a more sustained recovery pattern, and we may see some further increases in these contracts, which still have over a month until expiration.
Under Armour, Inc. UAA
We want to formulate an idea for Under Armour on the heels of the company’s earnings report this morning. The stock had already begun to trend off of its bottom a few sessions ago, and despite posting a Q4 loss, sales were better than expected and the stock is gapping up pretty significantly here in the premarket.
We’re going to want to keep tabs on the UAA Weekly $15.50-16.50 Calls, which could bring us sizable gain opportunities in the day or days to come.
Extended Watchlist:
APRI, CHGG, CBAY, MVIS, ADXS, MBRX, DCIX, THC